Influence of Parathyroidectomy on Bone Calcium Concentration: Evaluation with Spectral CT in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis-A Prospective Feasibility Study

被引:14
|
作者
Ma, Qiang [1 ]
Yang, Zhenghan [1 ]
Han, Xue [2 ]
Liu, Fen [3 ]
Su, Dechun [4 ]
Xing, Haidong [5 ]
机构
[1] Capital Med Univ, Dept Radiol, Beijing Friendship Hosp, 95 YongAn Rd, Beijing 100050, Peoples R China
[2] Capital Med Univ, Dept Nephrol, Beijing Friendship Hosp, 95 YongAn Rd, Beijing 100050, Peoples R China
[3] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Beijing, Peoples R China
[4] Dalian Med Univ, Dept Cardiol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China
[5] Capital Med Univ, Dept Radiol, Beijing Puren Hosp, Beijing, Peoples R China
关键词
MINERAL DENSITY; TRABECULAR BONE; RENAL HYPERPARATHYROIDISM; FEMORAL-NECK; ALENDRONATE; TURNOVER; STRENGTH; DISEASE; MARKERS; BMD;
D O I
10.1148/radiol.2016161797
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To use spectral computed tomography (CT) to evaluate the influence of parathyroidectomy (PTX) on calcium concentration in trabecular bone and cortical bone in patients undergoing hemodialysis with secondary hyperparathyroidism. Materials and Methods: This study was performed with institutional review board approval. Written consent was obtained from each patient. Thirty-eight men (mean age 6 standard deviation, 55.69 years +/- 8.05; range, 42-72 years) undergoing maintenance hemodialysis who underwent PTX and 40 patients (mean age, 56.71 years 6 9.53; range, 45-74 years) who did not undergo PTX received prospective follow-up for 2 years. Bone calcium concentration was measured in the cortical compartment of the bilateral proximal femur and the medullary compartment of the lumbar vertebral bodies (L1 through L3) on the basis of calcium-based material decomposition images of a spectral CT examination. The differences between baseline and end-of-study PTX parameters were analyzed with the paired Student t test. Results: For patients who underwent PTX, mean cortical bone calcium concentration increased from 220.69 mg/cm(3) +/- 25.79 to 257.43 mg/cm(3) +/- 25.46 (t = 8.546, P < 001), whereas medullary bone calcium concentration decreased from 64.75 mg/ cm(3) +/- 15.07 to 61.42 mg/cm(3) +/- 15.77 (t = 22.293, P,.001) from baseline to follow-up. In patients who did not undergo PTX, mean cortical bone calcium concentration decreased from 296.08 mg/cm(3) +/- 36.35 to 258.35 mg/cm(3) +/- 31.46 (t = 7.420, P < 001), but medullary bone calcium concentration increased from 61.13 mg/cm(3) +/- 13.85 to 62.94 mg/cm(3) +/- 14.80 (t = 2.370, P =.023) from baseline to follow-up. Conclusion: During the course of chronic renal failure, different bone elements involve various pathologic changes. PTX could reverse long-term cortical bone loss reflected in calcium concentration measured with spectral CT; however, it could induce medullary bone loss. (C) RSNA, 2017
引用
收藏
页码:143 / 152
页数:10
相关论文
共 50 条
  • [41] Efficacy and Tolerability of Intravenous Paricalcitol in Calcitriol-Resistant Hemodialysis Patients with Secondary Hyperparathyroidism: 12-Month Prospective Study
    Tonbul, Halil Zeki
    Solak, Yalcin
    Atalay, Huseyin
    Turkmen, Kultigin
    Altintepe, Lutfullah
    RENAL FAILURE, 2012, 34 (03) : 297 - 303
  • [42] Calcium-based phosphate binders and bone mineral density in patients undergoing hemodialysis: a retrospective cohort study
    Kato, Kazuhiko
    Nakashima, Akio
    Morishita, Masamitsu
    Ohkido, Ichiro
    Yokoo, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (09) : 917 - 924
  • [43] Prospective study of the short-term effect of 1.75 mmol/L calcium concentration dialysate on hemodialysis patients
    Zhang, Dongliang
    Sun, Fang
    Zhou, Yilun
    Duan, Xiaofeng
    Sun, Yi
    Cui, Taigen
    Liu, Wenhu
    FAMILY MEDICINE AND COMMUNITY HEALTH, 2014, 2 (02) : 15 - 21
  • [44] First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties
    Kazama, Junichiro James
    Koiwa, Fumihiko
    Yokoyama, Keitaro
    Fukagawa, Masafumi
    Asano, Kenji
    Honda, Daisuke
    Akizawa, Tadao
    CLINICAL PHARMACOKINETICS, 2022, 61 (09) : 1271 - 1284
  • [45] CONSISTENT MANAGEMENT OF MINERAL-AND-BONE DISORDER: A CASE-COHORT STUDY OF CAUSES OF DEATH IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Fukagawa, Masafumi
    Fukagawa, Masafumi
    Kido, Ryo
    Komaba, Hirotaka
    Onishi, Yoshihiro
    Yamaguch, Takuhiro
    Hasegawa, Takeshi
    Kurita, Noriaki
    Akizawa, Tadao
    Kurokawa, Kiyoshi
    Fukuhara, Shunichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 504 - 504
  • [46] Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
    Nobuo Nagano
    Takayuki Ishikawa
    Masashi Yamaguchi
    Yuji Katsuragi
    Masaaki Miya
    Noriko Tamei
    Shigeaki Muto
    Takaaki Tsutsui
    Tetsuya Ogawa
    Kyoko Ito
    Renal Replacement Therapy, 10
  • [47] Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
    Nagano, Nobuo
    Ishikawa, Takayuki
    Yamaguchi, Masashi
    Katsuragi, Yuji
    Miya, Masaaki
    Tamei, Noriko
    Muto, Shigeaki
    Tsutsui, Takaaki
    Ogawa, Tetsuya
    Ito, Kyoko
    RENAL REPLACEMENT THERAPY, 2024, 10 (01)
  • [48] First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties
    Junichiro James Kazama
    Fumihiko Koiwa
    Keitaro Yokoyama
    Masafumi Fukagawa
    Kenji Asano
    Daisuke Honda
    Tadao Akizawa
    Clinical Pharmacokinetics, 2022, 61 : 1271 - 1284
  • [49] Role of parathyroidectomy on anemia control and erythropoiesis-stimulating agent need in secondary hyperparathyroidism of chronic kidney disease. A retrospective study in 30 hemodialysis patients
    Conzo, Giovanni
    Perna, Alessandra
    Della Pietra, Cristina
    Esposito, Daniela
    Nunziata, Anna
    Palazzo, Antonietta
    Pizza, Alessandra
    Satta, Ersilia
    Sciascia, Valerio
    Santini, Luigi
    ANNALI ITALIANI DI CHIRURGIA, 2013, 84 (01) : 25 - 31
  • [50] An Open-Label, Prospective Pilot Clinical Study of Denosumab for Severe Hyperparathyroidism in Patients With Low Bone Mass Undergoing Dialysis
    Chen, Chien-Liang
    Chen, Nai-Ching
    Hsu, Chih-Yang
    Chou, Kang-Ju
    Lee, Po-Tsang
    Fang, Hua-Chang
    Renn, Jenn-Huei
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (07): : 2426 - 2432